Rosiglitazone accelerates wound healing by improving endothelial precursor cell function and angiogenesis in db/db mice

BACKGROUND & AIMS: Endothelial precursor cell (EPC) dysfunction is one of the risk factors for diabetes mellitus (DM) which results in delayed wound healing. Rosiglitazone (RSG) is a frequently prescribed oral glucose-lowering drug. Previous studies have shown the positive effects of RSG on amel...

Full description

Saved in:
Bibliographic Details
Published in:PeerJ
Main Authors: Zhou, Guoliang, Han, Xue, Wu, Zhiheng, Shi, Qiaojuan, Bao, Xiaogang
Format: Artigo
Language:Inglês
Published: PeerJ Inc. 2019
Subjects:
Cell Biology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800979/
https://ncbi.nlm.nih.gov/pubmed/31637120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.7815
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items